H. Conrad

发表

Allorestricted T lymphocytes with a high avidity T‐cell receptor towards NY‐ESO‐1 have potent anti‐tumor activity

D. Busch, P. Romero, C. Peschel, 2009, International journal of cancer.

Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6.

T. Rème, J. Rossi, B. Klein, 2013, Blood.

HLA-B*1832, a novel B allele was found through high-resolution HLA typing of a Spanish blood donor.

H. Conrad, T. Kauke, K. Witter, 2009, Tissue antigens.

Targeting the epidermal growth factor receptor (HER) family by T cell receptor gene-modified T lymphocytes

D. Busch, W. Uckert, M. Leisegang, 2010, Journal of Molecular Medicine.

NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability

W. Uckert, D. Sommermeyer, H. Bernhard, 2012, International journal of cancer.

A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes

M. Boutros, R. König, R. Offringa, 2015, EMBO molecular medicine.

FLT3-regulated antigens as targets for leukemia-reactive cytotoxic T lymphocytes

D. Busch, J. Adamski, C. Peschel, 2011, Blood cancer journal.

Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.

P. Di Bonito, F. Grasso, S. Mochi, 2009, Virology.

Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer

D. Busch, J. Nährig, W. Weber, 2007, Cancer Immunology, Immunotherapy.

Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells

D. Busch, S. Burdach, G. Richter, 2011, British Journal of Cancer.

CTLs Directed against HER2 Specifically Cross-React with HER3 and HER41

D. Busch, C. Peschel, H. Bernhard, 2008, The Journal of Immunology.

Cross-React with HER 3 and HER 4 CTLs Directed against HER 2 Specifically

D. Busch, C. Peschel, H. Bernhard, 2008 .

PD‐1 expression on Melan‐A‐reactive T cells increases during progression to metastatic disease

C. Blank, C. Peschel, B. Haller, 2012, International journal of cancer.

Tumor-Reactive T-Cells for Adoptive Immunotherapy

D. Busch, C. Peschel, H. Bernhard, 2006 .

molecule-6 cells through carcinoembryonic antigen-related cell adhesion Tumor cells in multiple myeloma patients inhibit myeloma-reactive

T. Rème, J. Rossi, B. Klein, 2013 .

HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients

F. Schuetz, C. Sohn, Y. Ge, 2013, Oncoimmunology.

Human Multiple Myeloma and Breast Cancer Cells Evade Immune Rejection Through Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6.

T. Rème, J. Rossi, B. Klein, 2012 .